Rocket


News + Filings
Holdings





All
13F
13D/G
Other


Palo Alto Investors LP Create: Alert

All | News | Filings
Date FiledTypeDescription
04/03/2023 SC 13G/A Palo Alto Investors LP reports a 0% stake in Alimera Sciences, Inc.
02/14/2023 SC 13G/A Palo Alto Investors LP reports a 11.4% stake in Alimera Sciences, Inc.
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 5.3% stake in Epizyme, Inc.
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 5.1% stake in Vanda Pharmaceuticals, Inc.
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 11.6% stake in Alimera Sciences, Inc.
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 2.4% stake in STAAR Surgical Co
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 5.1% stake in Insmed Inc.
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 3.1% stake in Clovis Oncology Inc.
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 6.1% stake in eHealth, Inc.
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Palo Alto Investors LP reports a 15.6% stake in Alimera Sciences, Inc.
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Palo Alto Investors, LLC reports a 8.5% stake in Vanda Pharmaceuticals, Inc.
02/14/2020 SC 13G/A Palo Alto Investors, LLC reports a 7.3% stake in Karyopharm Therapeutics Inc.
02/14/2020 SC 13G/A Palo Alto Investors, LLC reports a 6.8% stake in Epizyme, Inc.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Palo Alto Investors, LLC reports a 9.2% stake in Clovis Oncology Inc.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Palo Alto Investors, LLC reports a 16.2% stake in Alimera Sciences, Inc.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G Palo Alto Investors, LLC reports a 5.3% stake in Aimmune Therapeutics, Inc.
02/14/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
02/14/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/19/2019 SC 13G/A Palo Alto Investors, LLC reports a 8.3% stake in Vanda Pharmaceuticals, Inc.
02/14/2019 SC 13G/A Palo Alto Investors, LLC reports a 7.9% stake in Vanda Pharmaceuticals, Inc.
02/14/2019 SC 13G/A Palo Alto Investors, LLC reports a 8.5% stake in STAAR Surgical Company
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy